drugset / Trial / NCT03300804
Dose Escalation Trial of Traditional Chinese Medicine for Irritable Bowel Syndrome (TCM- IBS)
Phase 2
Completed
104 enrolled
University of Maryland, Baltimore
Chinese University of Hong Kong · collabNational Center for Complementary and Integrative Health (NCCIH) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine whether a 20- herb formulation, as a well characterised extract, is efficacious in treating irritable bowel syndrome (IBS) and also to identify efficacious and safe dosage of the formulation in treating IBS.
Timeline
- Start
- 2008-05
- Primary completion
- 2011-03
- Completion
- 2011-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | 20-herb formulation | Unknown | 17 g | — |
| Comparator | 20-herb formulation | Unknown | 34 g | — |